Molecular Diagnostics and Treatment Advances in Lung Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 584
Special Issue Editor
Interests: interstitial lung diseases; idiopathic pulmonary fibrosis; rare lung diseases; bronchoalveolar lavage; systemic autoimmune rheumatic diseases
Special Issue Information
Dear Colleagues,
I would like to invite you to participate in this Special Issue focused on the advancements in molecular diagnostics and treatment options for lung diseases. As our understanding of these conditions evolves, the need for innovative approaches to diagnosis and therapy is crucial. The investigation of molecular biomarkers might promote the early diagnosis of lung diseases, while deeper research on pathogenetic mechanisms will explore potential targeted therapies, hopefully leading to the enhancement of patient care through personalized medicine approaches.
We encourage the submission of research articles about the development of novel molecular diagnostic tools and treatment strategies that may significantly improve the patients’ outcomes and quality of life. Review articles on this topic are welcome as well. Both obstructive pulmonary diseases (COPD, asthma, bronchiectasis) and rare and interstitial lung diseases (ILDs) may be included.
We look forward to receiving your contributions.
Dr. Eirini Vasarmidi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung diseases
- pulmonary
- alveolar
- diagnosis
- treatment
- biomarkers
- molecular
- bronchoalveolar lavage
- genetics
- pathogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
